144 related articles for article (PubMed ID: 15561346)
1. Inflammation markers and erythrocyte sedimentation rate but not metabolic syndrome factor score predict coronary heart disease in high socioeconomic class males: the HDDRISC study.
Godsland IF; Bruce R; Jeffs JA; Leyva F; Walton C; Stevenson JC
Int J Cardiol; 2004 Dec; 97(3):543-50. PubMed ID: 15561346
[TBL] [Abstract][Full Text] [Related]
2. Serum uric acid is a determinant of metabolic syndrome in a population-based study.
Onat A; Uyarel H; Hergenç G; Karabulut A; Albayrak S; Sari I; Yazici M; Keleş I
Am J Hypertens; 2006 Oct; 19(10):1055-62. PubMed ID: 17027827
[TBL] [Abstract][Full Text] [Related]
3. Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis.
Coutinho Tde A; Turner ST; Peyser PA; Bielak LF; Sheedy PF; Kullo IJ
Am J Hypertens; 2007 Jan; 20(1):83-9. PubMed ID: 17198917
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
[TBL] [Abstract][Full Text] [Related]
5. Co-associations between insulin sensitivity and measures of liver function, subclinical inflammation, and hematology.
Godsland IF; Johnston DG
Metabolism; 2008 Sep; 57(9):1190-7. PubMed ID: 18702943
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance-related biomarker clustering and subclinical inflammation as predictors of cancer mortality during 21.5 years of follow-up.
Loh WJ; North BV; Johnston DG; Godsland IF
Cancer Causes Control; 2010 May; 21(5):709-18. PubMed ID: 20072808
[TBL] [Abstract][Full Text] [Related]
7. Relationship between metabolic syndrome and its components with coronary heart disease in Iranian men and women.
Zabetian A; Hadaegh F; Azizi F
Exp Clin Endocrinol Diabetes; 2008 Oct; 116(9):525-31. PubMed ID: 18523915
[TBL] [Abstract][Full Text] [Related]
8. Serum total and high-density lipoprotein phospholipid levels in a population-based study and relationship to risk of metabolic syndrome and coronary disease.
Hergenç G; Onat A; Sari I; Yazici M; Eryonucu B; Can G
Angiology; 2008; 59(1):26-35. PubMed ID: 18319219
[TBL] [Abstract][Full Text] [Related]
9. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.
Onat A; Sari I; Yazici M; Can G; Hergenç G; Avci GS
Int J Cardiol; 2006 Mar; 108(1):89-95. PubMed ID: 16085325
[TBL] [Abstract][Full Text] [Related]
10. Components of metabolic syndrome predicting diabetes: no role of inflammation or dyslipidemia.
Norberg M; Stenlund H; Lindahl B; Andersson C; Weinehall L; Hallmans G; Eriksson JW
Obesity (Silver Spring); 2007 Jul; 15(7):1875-85. PubMed ID: 17636107
[TBL] [Abstract][Full Text] [Related]
11. Long-term cardiac rehabilitation and exercise training programs improve metabolic parameters in metabolic syndrome patients with and without coronary heart disease.
Gayda M; Brun C; Juneau M; Levesque S; Nigam A
Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):142-51. PubMed ID: 17142023
[TBL] [Abstract][Full Text] [Related]
12. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
Lorenzo C; Williams K; Hunt KJ; Haffner SM
Diabetes Care; 2007 Jan; 30(1):8-13. PubMed ID: 17192325
[TBL] [Abstract][Full Text] [Related]
13. Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count, and erythrocyte sedimentation rate: comparison study in an elderly population.
Muscari A; Antonelli S; Bianchi G; Cavrini G; Dapporto S; Ligabue A; Ludovico C; Magalotti D; Poggiopollini G; Zoli M;
Diabetes Care; 2007 Sep; 30(9):2362-8. PubMed ID: 17595349
[TBL] [Abstract][Full Text] [Related]
14. Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study.
Jacobs M; van Greevenbroek MM; van der Kallen CJ; Ferreira I; Blaak EE; Feskens EJ; Jansen EH; Schalkwijk CG; Stehouwer CD
Eur J Clin Invest; 2009 Jun; 39(6):437-44. PubMed ID: 19397692
[TBL] [Abstract][Full Text] [Related]
15. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
[TBL] [Abstract][Full Text] [Related]
16. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study.
Hanley AJ; Karter AJ; Williams K; Festa A; D'Agostino RB; Wagenknecht LE; Haffner SM
Circulation; 2005 Dec; 112(24):3713-21. PubMed ID: 16344402
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein (IGFBP)-3 levels in Arab subjects with coronary heart disease.
Akanji AO; Suresh CG; Al-Radwan R; Fatania HR
Scand J Clin Lab Invest; 2007; 67(5):553-9. PubMed ID: 17763192
[TBL] [Abstract][Full Text] [Related]
18. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey.
Miller M; Zhan M; Havas S
Arch Intern Med; 2005 Oct; 165(18):2063-8. PubMed ID: 16216995
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.
Kim SH; Chunawala L; Linde R; Reaven GM
J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178
[TBL] [Abstract][Full Text] [Related]
20. Weight loss improves heart rate recovery in overweight and obese men with features of the metabolic syndrome.
Brinkworth GD; Noakes M; Buckley JD; Clifton PM
Am Heart J; 2006 Oct; 152(4):693.e1-6. PubMed ID: 16996838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
